Parkinson’s Disease: RO7568282 Safety Study

We are testing a new drug, RO7568282, to see if it is safe for healthy people and those with Parkinson’s disease. This study will help us understand its effects on the body.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Brain Research Center Den Bosch B.V.
's-Hertogenbosch, Netherlands
Brain Research Center Amsterdam B.V.
Amstelveen, Netherlands
Pharmaceutical Research Associates Group B.V.
Program Management
Groningen, Netherlands

Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.